| +380 44 495-10-14 |
rus | eng
|
|
CetrotideATC code: H01C C02
Active ingredient: Cetrorelix Cetrorelix is a luteinising hormone releasing hormone (LHRH) antagonist.
International name: Cetrorelix (as cetrorelix acetate)
Pharmacotherapeutic group
LHRH-antagonist Cetrorelix dose-dependently inhibits the secretion LH and FSH from the pituitary gland. Indications: Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. Cetrotide 0,25 mg Registration status: UA/4898/01/01; expiry date: 01.08.2011 Dosage: 0,25 mg Packaging: 1 vial with powder + 1 PFS + 2 needles Shelf-life (months): 24 Cetrotide 3 mg Registration status: UA/4898/01/02; expiry date:01.08.2011 Dosage: 3 mg Packaging: 1 vial with powder + 1 PFS + 2 needles Shelf-life (months): 24 |
15.11.2011
04.06.2011
02.04.2011
29.05.2010
21.05.2010
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sona-Pharm LLC
Ukraine, 03680 Kyiv Mykoly Grinchenka Str., 4 Теl: +38 044 495 10 14 Fax: +38 044 495 10 15 office@sona-pharm.com.ua |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||